At the same time, the study also confirmed that for PCa patients with low PSA concentration (≤2.0 ng/mL) and BCR after radical prostatectomy, PSMA marker tracer can be used as the preferred PET tracer in subsequent treatment decision-making, with a high DR. Here, FOLH1 is linked to posterior cortical atrophy.